Sinovac Biotech, Ltd
SVA
SVA was delisted on the 22nd of February, 2019.
40 hedge funds and large institutions have $72.5M invested in Sinovac Biotech, Ltd in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 8 closing their positions.
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
8% more funds holding
Funds holding: 37 → 40 (+3)
8% more capital invested
Capital invested by funds: $67.3M → $72.5M (+$5.15M)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
50% less call options, than puts
Call options by funds: $1K | Put options by funds: $2K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.48M |
| 2 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$1.28M |
| 3 |
Renaissance Technologies
New York
|
+$330K |
| 4 |
Two Sigma Investments
New York
|
+$262K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$157K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.08M |
| 2 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$2.67M |
| 3 |
Morgan Stanley
New York
|
-$754K |
| 4 |
ProShare Advisors
Bethesda,
Maryland
|
-$216K |
| 5 |
Barclays
London,
United Kingdom
|
-$81.9K |
SVA Hedge Fund Activity: Q4 2015 in Review
40 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q4 2015, worth a combined $72.5M — up 7.6% from $67.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new SVA positions and 8 closed out — a net gain of 3 holders — while 8 added to existing stakes and 12 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $3.48M. The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $4.08M sold.
- 40 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q4 2015, up from 37 in Q3 2015.
- Funds reported $72.5M of Sinovac Biotech, Ltd stock for Q4 2015, up 7.6% quarter-over-quarter.
- 11 funds opened new Sinovac Biotech, Ltd positions in Q4 2015 and 8 closed out, a net change of +3 holders.
- The largest Sinovac Biotech, Ltd buyer in Q4 2015 was Wellington Management Group, an estimated $3.48M added.
- The largest Sinovac Biotech, Ltd seller in Q4 2015 was BlackRock Fund Advisors, an estimated $4.08M sold.
Based on aggregated 13F filings for Q4 2015.